Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
United States Department of Veterans Affairs | 11 | 2015 | 937 | 0.910 |
Why?
|
Fee-for-Service Plans | 8 | 2014 | 713 | 0.490 |
Why?
|
Medicare | 25 | 2014 | 6813 | 0.490 |
Why?
|
Healthcare Disparities | 5 | 2014 | 3414 | 0.470 |
Why?
|
Quality of Health Care | 15 | 2015 | 4306 | 0.460 |
Why?
|
Hospitals, Veterans | 7 | 2015 | 395 | 0.420 |
Why?
|
SEER Program | 18 | 2014 | 1444 | 0.410 |
Why?
|
Colorectal Neoplasms | 13 | 2015 | 6966 | 0.400 |
Why?
|
Skin Diseases, Infectious | 1 | 2012 | 75 | 0.390 |
Why?
|
Soft Tissue Infections | 1 | 2012 | 166 | 0.350 |
Why?
|
Reimbursement, Incentive | 3 | 2012 | 541 | 0.340 |
Why?
|
Lung Neoplasms | 19 | 2015 | 13491 | 0.330 |
Why?
|
Veterans | 3 | 2012 | 2666 | 0.330 |
Why?
|
Quality Indicators, Health Care | 13 | 2015 | 1804 | 0.320 |
Why?
|
Hospital Administration | 1 | 2012 | 350 | 0.300 |
Why?
|
Guideline Adherence | 8 | 2012 | 2232 | 0.300 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2015 | 5389 | 0.300 |
Why?
|
Minority Groups | 3 | 2012 | 1214 | 0.290 |
Why?
|
Pneumonectomy | 2 | 2011 | 1147 | 0.280 |
Why?
|
Propensity Score | 3 | 2013 | 1971 | 0.270 |
Why?
|
Myocardial Infarction | 17 | 2010 | 11513 | 0.270 |
Why?
|
Coronary Angiography | 9 | 2004 | 4525 | 0.270 |
Why?
|
Bayes Theorem | 3 | 2014 | 2353 | 0.260 |
Why?
|
Cluster Analysis | 1 | 2013 | 2721 | 0.260 |
Why?
|
Rectal Neoplasms | 2 | 2012 | 1183 | 0.260 |
Why?
|
United States | 53 | 2015 | 72971 | 0.250 |
Why?
|
Models, Statistical | 7 | 2014 | 5098 | 0.230 |
Why?
|
Health Services Misuse | 4 | 2014 | 246 | 0.220 |
Why?
|
Neoplasms | 16 | 2015 | 22350 | 0.220 |
Why?
|
Health Expenditures | 4 | 2013 | 2390 | 0.220 |
Why?
|
Antimanic Agents | 1 | 2007 | 524 | 0.220 |
Why?
|
Colonic Neoplasms | 3 | 2011 | 2535 | 0.210 |
Why?
|
Small-Area Analysis | 3 | 2014 | 51 | 0.210 |
Why?
|
Managed Care Programs | 6 | 2007 | 939 | 0.200 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1787 | 0.200 |
Why?
|
Breast Neoplasms | 15 | 2014 | 21178 | 0.200 |
Why?
|
Aged, 80 and over | 36 | 2015 | 59548 | 0.180 |
Why?
|
Hospice Care | 6 | 2011 | 678 | 0.180 |
Why?
|
Cost of Illness | 2 | 2008 | 1951 | 0.170 |
Why?
|
Patient Admission | 1 | 2007 | 1364 | 0.170 |
Why?
|
Aged | 59 | 2015 | 171319 | 0.170 |
Why?
|
Quality Assurance, Health Care | 5 | 2008 | 2174 | 0.160 |
Why?
|
Health Care Costs | 3 | 2012 | 3239 | 0.160 |
Why?
|
Hospitals | 5 | 2012 | 3883 | 0.160 |
Why?
|
Terminal Care | 5 | 2010 | 1770 | 0.160 |
Why?
|
Practice Guidelines as Topic | 9 | 2012 | 7435 | 0.160 |
Why?
|
Physician-Patient Relations | 6 | 2015 | 3266 | 0.150 |
Why?
|
Sterol O-Acyltransferase | 1 | 1998 | 28 | 0.150 |
Why?
|
Psychotherapy | 1 | 2007 | 1653 | 0.150 |
Why?
|
Medicare Part C | 2 | 2013 | 333 | 0.140 |
Why?
|
Patient Preference | 2 | 2015 | 947 | 0.140 |
Why?
|
Cost Sharing | 2 | 2013 | 409 | 0.140 |
Why?
|
Apolipoprotein A-I | 1 | 1998 | 305 | 0.130 |
Why?
|
Health Maintenance Organizations | 2 | 2012 | 656 | 0.120 |
Why?
|
Logistic Models | 20 | 2015 | 13284 | 0.120 |
Why?
|
Medicaid | 2 | 2007 | 2836 | 0.110 |
Why?
|
Competitive Bidding | 1 | 2013 | 16 | 0.110 |
Why?
|
Ambulatory Care | 5 | 2007 | 2780 | 0.110 |
Why?
|
Male | 56 | 2015 | 364203 | 0.110 |
Why?
|
Survivors | 4 | 2009 | 2381 | 0.110 |
Why?
|
Hospices | 2 | 2014 | 245 | 0.110 |
Why?
|
Age Factors | 10 | 2014 | 18401 | 0.110 |
Why?
|
Humans | 86 | 2015 | 767040 | 0.110 |
Why?
|
Patient Satisfaction | 4 | 2015 | 3488 | 0.110 |
Why?
|
Female | 61 | 2015 | 396660 | 0.110 |
Why?
|
Military Personnel | 2 | 2012 | 1261 | 0.100 |
Why?
|
Patient Participation | 4 | 2015 | 1444 | 0.100 |
Why?
|
Patient Care Team | 2 | 2015 | 2516 | 0.100 |
Why?
|
Patient Selection | 5 | 2009 | 4256 | 0.100 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2012 | 34 | 0.100 |
Why?
|
Contracts | 1 | 2012 | 60 | 0.100 |
Why?
|
Monte Carlo Method | 2 | 2013 | 1250 | 0.100 |
Why?
|
Residence Characteristics | 4 | 2014 | 2116 | 0.100 |
Why?
|
Competitive Behavior | 1 | 2012 | 77 | 0.100 |
Why?
|
Terminally Ill | 1 | 2014 | 240 | 0.100 |
Why?
|
Decision Making | 6 | 2015 | 3951 | 0.100 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2011 | 33 | 0.090 |
Why?
|
Early Detection of Cancer | 3 | 2015 | 3236 | 0.090 |
Why?
|
Survival Analysis | 5 | 2015 | 10092 | 0.090 |
Why?
|
Urban Population | 2 | 2014 | 2044 | 0.090 |
Why?
|
Bipolar Disorder | 2 | 2013 | 5130 | 0.090 |
Why?
|
Survival | 1 | 2011 | 160 | 0.090 |
Why?
|
Interdisciplinary Communication | 2 | 2015 | 935 | 0.090 |
Why?
|
Budgets | 1 | 2012 | 232 | 0.090 |
Why?
|
Comorbidity | 7 | 2012 | 10582 | 0.090 |
Why?
|
Data Collection | 7 | 2009 | 3321 | 0.090 |
Why?
|
Longitudinal Studies | 6 | 2012 | 14766 | 0.090 |
Why?
|
Medical Records | 2 | 2014 | 1409 | 0.090 |
Why?
|
Treatment Refusal | 2 | 2011 | 433 | 0.090 |
Why?
|
Insurance Coverage | 2 | 2013 | 1945 | 0.090 |
Why?
|
Benchmarking | 2 | 2013 | 1056 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2014 | 434 | 0.080 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 454 | 0.080 |
Why?
|
Socioeconomic Factors | 5 | 2014 | 7848 | 0.080 |
Why?
|
Health Services Research | 6 | 2013 | 1815 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2012 | 419 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1741 | 0.080 |
Why?
|
Health Care Surveys | 6 | 2015 | 2428 | 0.080 |
Why?
|
HIV Infections | 3 | 2012 | 17542 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 848 | 0.080 |
Why?
|
Middle Aged | 34 | 2015 | 223233 | 0.080 |
Why?
|
Cost Savings | 2 | 2012 | 904 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2012 | 6215 | 0.080 |
Why?
|
Models, Organizational | 1 | 2012 | 548 | 0.080 |
Why?
|
Medicare Part D | 1 | 2013 | 355 | 0.080 |
Why?
|
Commerce | 1 | 2013 | 614 | 0.080 |
Why?
|
Program Evaluation | 3 | 2013 | 2505 | 0.080 |
Why?
|
Preferred Provider Organizations | 1 | 2007 | 36 | 0.070 |
Why?
|
Primary Health Care | 6 | 2007 | 4746 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1621 | 0.070 |
Why?
|
Health Services Accessibility | 4 | 2014 | 5519 | 0.070 |
Why?
|
Formularies as Topic | 1 | 2007 | 94 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3552 | 0.070 |
Why?
|
Referral and Consultation | 5 | 2007 | 3618 | 0.070 |
Why?
|
Patient Compliance | 2 | 2007 | 2697 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Family Practice | 3 | 2005 | 509 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2012 | 963 | 0.070 |
Why?
|
Prostatic Neoplasms | 6 | 2015 | 11097 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2698 | 0.070 |
Why?
|
Odds Ratio | 4 | 2015 | 9660 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1788 | 0.070 |
Why?
|
Registries | 5 | 2013 | 8351 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1405 | 0.060 |
Why?
|
Cohort Studies | 14 | 2013 | 41718 | 0.060 |
Why?
|
Regression Analysis | 6 | 2010 | 6331 | 0.060 |
Why?
|
Medical Oncology | 4 | 2007 | 2341 | 0.060 |
Why?
|
Income | 3 | 2009 | 1877 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2015 | 4054 | 0.060 |
Why?
|
Health Facilities | 1 | 2009 | 578 | 0.060 |
Why?
|
Delphi Technique | 2 | 1999 | 891 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 115 | 0.060 |
Why?
|
Cardiology | 3 | 2006 | 1701 | 0.060 |
Why?
|
Neoplasm Staging | 8 | 2015 | 11217 | 0.060 |
Why?
|
Computer Simulation | 2 | 2013 | 6260 | 0.060 |
Why?
|
Patient Care | 1 | 2009 | 628 | 0.060 |
Why?
|
Family | 1 | 2015 | 3210 | 0.060 |
Why?
|
Prostatectomy | 1 | 2012 | 1786 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2009 | 1149 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12536 | 0.050 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 412 | 0.050 |
Why?
|
Employment | 1 | 2009 | 1110 | 0.050 |
Why?
|
Communication | 3 | 2015 | 3904 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 951 | 0.050 |
Why?
|
Radiation Oncology | 1 | 2009 | 572 | 0.050 |
Why?
|
Population Surveillance | 3 | 2013 | 2594 | 0.050 |
Why?
|
Practice Management, Medical | 1 | 2004 | 191 | 0.050 |
Why?
|
Minnesota | 4 | 2004 | 339 | 0.050 |
Why?
|
Adult | 21 | 2015 | 223317 | 0.050 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12069 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1188 | 0.050 |
Why?
|
Trust | 1 | 2007 | 532 | 0.050 |
Why?
|
Gatekeeping | 1 | 2001 | 49 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1433 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3591 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2014 | 4892 | 0.050 |
Why?
|
Diabetes Mellitus | 3 | 2004 | 5886 | 0.050 |
Why?
|
Hospital Costs | 1 | 2007 | 956 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2337 | 0.050 |
Why?
|
Mastectomy, Segmental | 2 | 2010 | 974 | 0.050 |
Why?
|
Insurance, Health | 2 | 2013 | 2519 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6513 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2007 | 788 | 0.050 |
Why?
|
Human Experimentation | 1 | 2001 | 125 | 0.050 |
Why?
|
Survival Rate | 2 | 2012 | 12823 | 0.050 |
Why?
|
Aftercare | 1 | 2007 | 915 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2010 | 5363 | 0.050 |
Why?
|
Androgen Antagonists | 1 | 2009 | 1412 | 0.040 |
Why?
|
Tobacco Industry | 1 | 2002 | 139 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2015 | 65295 | 0.040 |
Why?
|
Utilization Review | 2 | 2001 | 381 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3530 | 0.040 |
Why?
|
Birth Rate | 1 | 2001 | 168 | 0.040 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3078 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5537 | 0.040 |
Why?
|
Medicine | 3 | 2010 | 944 | 0.040 |
Why?
|
Self Care | 1 | 2004 | 800 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2490 | 0.040 |
Why?
|
Prospective Studies | 6 | 2015 | 54886 | 0.040 |
Why?
|
Health Services | 1 | 2004 | 755 | 0.040 |
Why?
|
Cholesterol Esters | 1 | 1998 | 68 | 0.040 |
Why?
|
Normal Distribution | 1 | 1999 | 267 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8048 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2299 | 0.040 |
Why?
|
Anticholesteremic Agents | 2 | 2002 | 969 | 0.040 |
Why?
|
Circular Dichroism | 1 | 1998 | 333 | 0.040 |
Why?
|
Mammography | 2 | 2006 | 2431 | 0.040 |
Why?
|
Specialization | 2 | 2001 | 778 | 0.040 |
Why?
|
Tamoxifen | 1 | 2002 | 966 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2010 | 3253 | 0.040 |
Why?
|
Cost Control | 2 | 2012 | 627 | 0.040 |
Why?
|
Inpatients | 1 | 2009 | 2563 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 609 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2010 | 13650 | 0.040 |
Why?
|
Epitope Mapping | 1 | 1998 | 301 | 0.030 |
Why?
|
Massachusetts | 6 | 2012 | 8890 | 0.030 |
Why?
|
Expert Testimony | 1 | 1999 | 266 | 0.030 |
Why?
|
Incidence | 2 | 2012 | 21526 | 0.030 |
Why?
|
Quality Improvement | 1 | 2012 | 3854 | 0.030 |
Why?
|
Cholesterol | 2 | 2004 | 2905 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 1902 | 0.030 |
Why?
|
Solubility | 1 | 1998 | 1078 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 781 | 0.030 |
Why?
|
Retrospective Studies | 12 | 2015 | 81659 | 0.030 |
Why?
|
Electrocardiography | 2 | 2006 | 6409 | 0.030 |
Why?
|
Databases, Factual | 3 | 2011 | 8068 | 0.030 |
Why?
|
Interviews as Topic | 3 | 2013 | 2741 | 0.030 |
Why?
|
Markov Chains | 1 | 1999 | 976 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1211 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2912 | 0.030 |
Why?
|
California | 2 | 2014 | 1439 | 0.030 |
Why?
|
Physician's Role | 1 | 2001 | 923 | 0.030 |
Why?
|
Iowa | 1 | 2014 | 100 | 0.030 |
Why?
|
Phospholipids | 1 | 1998 | 778 | 0.030 |
Why?
|
Alabama | 1 | 2014 | 112 | 0.030 |
Why?
|
Risk Factors | 5 | 2014 | 74886 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5186 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2002 | 1536 | 0.030 |
Why?
|
Smoking | 3 | 2010 | 9081 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 1998 | 679 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 329 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14672 | 0.030 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 65 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3928 | 0.030 |
Why?
|
Physicians | 2 | 2008 | 4593 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2013 | 2920 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39317 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2662 | 0.030 |
Why?
|
Veterans Health | 1 | 2014 | 216 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1998 | 3052 | 0.030 |
Why?
|
Health Status | 1 | 2005 | 4091 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1998 | 3587 | 0.020 |
Why?
|
Empirical Research | 1 | 2012 | 119 | 0.020 |
Why?
|
Costs and Cost Analysis | 2 | 2012 | 1666 | 0.020 |
Why?
|
Anxiety | 1 | 2007 | 4670 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 1002 | 0.020 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2012 | 92 | 0.020 |
Why?
|
Time Factors | 5 | 2015 | 40154 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2012 | 301 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2012 | 286 | 0.020 |
Why?
|
Mental Health | 1 | 2005 | 3272 | 0.020 |
Why?
|
Young Adult | 6 | 2015 | 59980 | 0.020 |
Why?
|
Office Visits | 2 | 2007 | 595 | 0.020 |
Why?
|
Rural Population | 1 | 2001 | 2321 | 0.020 |
Why?
|
Drug Utilization | 2 | 2007 | 1190 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30211 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3948 | 0.020 |
Why?
|
Prognosis | 4 | 2015 | 29963 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2002 | 2085 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2015 | 1141 | 0.020 |
Why?
|
Awareness | 1 | 2014 | 653 | 0.020 |
Why?
|
Viral Load | 2 | 2012 | 3385 | 0.020 |
Why?
|
Comprehension | 1 | 2015 | 636 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4859 | 0.020 |
Why?
|
Intensive Care Units | 3 | 2010 | 3797 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2509 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1205 | 0.020 |
Why?
|
Health Personnel | 1 | 2002 | 3387 | 0.020 |
Why?
|
Models, Economic | 1 | 2012 | 719 | 0.020 |
Why?
|
Private Sector | 1 | 2011 | 397 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2009 | 300 | 0.020 |
Why?
|
Hospitalization | 4 | 2013 | 10815 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1512 | 0.020 |
Why?
|
Pneumonia | 2 | 2010 | 2159 | 0.020 |
Why?
|
Mastectomy | 2 | 2010 | 1861 | 0.020 |
Why?
|
Biostatistics | 1 | 2009 | 162 | 0.020 |
Why?
|
Incidental Findings | 1 | 2012 | 698 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2006 | 1721 | 0.020 |
Why?
|
Depression | 1 | 2007 | 8234 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 2850 | 0.020 |
Why?
|
Financing, Personal | 1 | 2009 | 310 | 0.020 |
Why?
|
Demography | 2 | 2002 | 1641 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 314 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1298 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2586 | 0.020 |
Why?
|
Protein Binding | 1 | 1998 | 9327 | 0.020 |
Why?
|
Community Health Services | 1 | 2009 | 659 | 0.010 |
Why?
|
Algorithms | 3 | 2014 | 14098 | 0.010 |
Why?
|
Health Care Reform | 1 | 2013 | 1256 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3344 | 0.010 |
Why?
|
Sex Factors | 3 | 2002 | 10622 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1999 | 20169 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2227 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2010 | 727 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 2002 | 2189 | 0.010 |
Why?
|
Internal Medicine | 2 | 2002 | 1064 | 0.010 |
Why?
|
Radiotherapy | 1 | 2010 | 1500 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2007 | 697 | 0.010 |
Why?
|
Health Care Sector | 1 | 2005 | 196 | 0.010 |
Why?
|
Insurance Claim Review | 1 | 2007 | 744 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11872 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 631 | 0.010 |
Why?
|
Quality of Life | 1 | 2003 | 13485 | 0.010 |
Why?
|
Ethics | 1 | 2001 | 93 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 4026 | 0.010 |
Why?
|
Role | 1 | 2002 | 176 | 0.010 |
Why?
|
Medication Adherence | 1 | 2013 | 2191 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11063 | 0.010 |
Why?
|
Risk Assessment | 2 | 2002 | 24299 | 0.010 |
Why?
|
Axilla | 1 | 2003 | 622 | 0.010 |
Why?
|
American Heart Association | 1 | 2006 | 1049 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2001 | 285 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 663 | 0.010 |
Why?
|
Insurance Claim Reporting | 1 | 2001 | 166 | 0.010 |
Why?
|
Cardiology Service, Hospital | 1 | 2002 | 242 | 0.010 |
Why?
|
Ethics Committees, Research | 1 | 2001 | 196 | 0.010 |
Why?
|
Florida | 1 | 2001 | 417 | 0.010 |
Why?
|
Taxes | 1 | 2002 | 220 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2783 | 0.010 |
Why?
|
Research Design | 2 | 2005 | 6210 | 0.010 |
Why?
|
State Government | 1 | 2002 | 388 | 0.010 |
Why?
|
Mass Screening | 2 | 2005 | 5456 | 0.010 |
Why?
|
General Surgery | 1 | 2010 | 1720 | 0.010 |
Why?
|
New England | 1 | 2001 | 1058 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2001 | 688 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 89046 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7871 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 2006 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2003 | 1267 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 934 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8535 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3700 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9360 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1188 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2006 | 2054 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4567 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1472 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1243 | 0.010 |
Why?
|
Software | 1 | 2009 | 4472 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13646 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6951 | 0.010 |
Why?
|
Life Expectancy | 1 | 2002 | 1248 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 6975 | 0.010 |
Why?
|
Schizophrenia | 1 | 2013 | 6977 | 0.010 |
Why?
|
Health Behavior | 1 | 2005 | 2650 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2252 | 0.010 |
Why?
|
Educational Status | 1 | 2001 | 2511 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2936 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15925 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2001 | 1664 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9362 | 0.010 |
Why?
|
Mental Health Services | 1 | 2002 | 1733 | 0.010 |
Why?
|
Aspirin | 1 | 2001 | 3135 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2005 | 22254 | 0.000 |
Why?
|
Cardiovascular Diseases | 2 | 2002 | 15645 | 0.000 |
Why?
|
Heart Failure | 1 | 2010 | 11877 | 0.000 |
Why?
|
Aging | 1 | 2003 | 8729 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 26325 | 0.000 |
Why?
|